Abstract
UDP-GlcNAc:Manα1-3R β1-2-N-acetylglucosaminyltransferase I (GlcNAc-T I; EC 2.4.1.101) catalyses the conversion of [Manα1-6(Manα1-3)Manα1-6][Manα1-3]Manβ-O-R to [Manα1-6(Manα1-3)Manα1-6] [GlcNAcβ1-2Manα1-3]Manβ-O-R (R=1-4GlcNAcβ1-4GlcNAc-Asn-X) and thereby controls the conversion of oligomannose to complex and hybrid asparagine-linked glycans (N-glycans). GlcNAc-T I also catalyses the conversion of Manα1-6(Manα1-3)Manβ-O-octyl to Manα1-6(GlcNAcβ1-2Manα1-3)Manβ-O-octyl. We have therefore tested a series of synthetic analogues of Man″α1-6(Man′α1-3)Manβ-O-octyl as substrates and inhibitors for rat liver GlcNAc-T I. The 2″-deoxy and the 3″-, 4″- and 6″-O-methyl derivatives are all good substrates confirming previous observations that the hydroxyl groups of the Man″α1-6 residue do not play major roles in the binding of substrate to enzyme. In contrast, all four hydroxyl groups on the Man′α1-3 residue are essential since the corresponding deoxy derivatives either do not bind (2′- and 3′-deoxy) or bind very poorly (4′- and 6′-deoxy) to the enzyme. The 2′- and 3′-O-methyl derivatives also do not bind to the enzyme. However, the 4′-O-methyl derivative is a substrate (K m =2.6mm) and the 6′-O-methyl compound is a competitive inhibitor (K i=0.76mm). We have therefore synthesized various 4′- and 6′-O-alkyl derivatives, some with reactive groups attached to anO-pentyl spacer, and tested these compounds as reversible and irreversible inhibitors of GlcNAc-T I. The 6′-O-(5-iodoacetamido-pentyl) compound is a specific time dependent inhibitor of the enzyme. Four other 6′-O-alkyl compounds showed competitive inhibition while the remaining compounds showed little or no binding indicating that the electronic properties of the attachedO-pentyl groups influence binding.
Similar content being viewed by others
Abbreviations
- GlcNAc-T I:
-
UDP-GlcNAc:Manα1-3R β1-2-N-acetylglucosaminyltransferase I (EC 2.4.1.101)
- GlcNAc-T II:
-
UDP-GlcNAc:Manα1-6R β1-2-N-acetylglucosaminyltransferase II (EC 2.4.1.143)
- MES:
-
2-(N-morpholino)ethane sulfonic acid monohydrate
References
Varki A (1993)Glycobiology 3: 97–130.
Schachter H (1986)Biochem Cell Biol 64: 163–81.
Schachter H (1991)Glycobiology 1: 453–61.
Stanley, P, Narasimhan S, Siminovitch L, Schachter H (1975)Proc Nat Acad Sci (USA) 72: 3323–27.
Narasimhan S, Stanley P, Schachter H (1977)J Biol Chem 252: 3926–33.
Kumar R, Stanley P (1989)Mol Cell Biol 9: 5713–17.
Metzler M, Gertz A, Sarkar M, Schachter H, Schrader JW, Marth JD (1994)EMBO J 13: 2056–65.
Ioffe E, Stanley P (1994)Proc Natl Acad Sci USA 91: 728–32.
Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS (1987)Science 236: 582–85.
Rademacher TW, Parekh RB, Dwek RA (1988)Ann Rev Biochem 57: 785–838.
West CM (1986)Mol Cell Biochem 72: 3–20.
Lis H, Sharon N (1993)Eur J Biochem 218: 1–27.
Brockhausen I, Carver J, Schachter H (1988)Biochem Cell Biol 66: 1134–51.
Schachter H, Brockhausen I, Hull E (1989)Methods Enzymol 179: 351–96.
Elbein AD (1987)Ann Rev Biochem 56: 497–534.
Elbein AD (1991)FASEB J 5: 3055–63.
Paulsen H, Reck F, Brockhausen I (1992)Carbohydr Res 236: 39–71.
Paulsen H, Springer M, Reck F, Meinjohanns E, Brockhausen I, Schachter H (1995)Liebigs Ann 53–66.
Paulsen H, Springer M, Reck F, Brockhausen I, Schachter H (1995)Liebigs Ann 67–76.
Reck F, Meinjohanns E, Springer M, Wilkens R, van Dorst JALM, Paulsen H, Möller G, Brockhausen I, Schachter H (1994)Glycoconjugate J 11: 210–16.
Reck F, Springer M, Paulsen H, Brockhausen I, Sarkar M, Schachter H (1994)Carbohydr Res 259: 93–101.
Kaur KJ, Alton G, Hindsgaul O (1991)Carbohydr Res 210: 145–53.
Kaur KJ, Hindsgaul O (1991)Glycoconjugate J 8: 90–94.
Kaur KJ, Hindsgaul O (1992)Carbohydr Res 226: 219–31.
Srivastava G, Alton G, Hindsgaul O (1990)Carbohydr Res 207: 259–76.
Hindsgaul O, Kaur KJ, Srivastava G, Blaszczyk-Thurin M, Crawley SC, Heerze LD, Palcic MM (1991)J Biol Chem 266: 17858–62.
Linker T, Crawley SC, Hindsgaul O (1993)Carbohydr Res 245: 323–31.
Kanie O, Crawley SC, Palcic MM, Mindsgual O (1993)Carbohydr Res 243: 139–64.
Khan SH, Matta KL (1993)Carbohydr Res 243: 29–42.
Möller G, Reck F, Paulsen H, Kaur KJ, Sarkar M, Schachter H, Brockhausen I (1992)Glycoconjugate J 9: 180–90.
Nishikawa Y, Pegg W, Paulsen H, Schachter H (1988)J Biol Chem 263: 8270–81.
Vella GJ, Paulsen H, Schachter H (1984)Can J Biochem Cell Biol 62: 409–17.
Brockhausen I, Möller G, Yang JM, Khan SH, Matta KL, Paulsen H, Grey AA, Shah RN, Schachter H (1992)Carbohydr Res 236: 281–99.
Wlasichuk KB, Kashem MA, Nikrad PV, Bird P, Jiang C, Venot AP (1993)J Biol Chem 268: 13971–77.
Roseman S, Distler JJ, Moffat JG, Khorana HG (1961)J Am Chem Soc 83: 659–63.
Reck F (1991) Synthese von modifizierten oligosaccharid-sequenzen derN-glycoproteine als substrate oder inhibitoren für dieN-acetylglucosaminyltransferase I. PhD thesis, University of Hamburg, Hamburg, Germany.
Harpaz N, Schachter H (1980)J Biol Chem 255: 4885–93.
Brockhausen I, Reck F, Kuhns W, Khan S, Matta KL, Meinjohanns E, Paulsen H, Shah RN, Baker MA, Schachter H (1995)Glycoconjugate J 12: 371–79.
Khan SH, Crawley SC, Kanie O, Hindsgaul O (1993)J Biol Chem 268: 2468–73.
Ats SC, Lehmann J, Petry S (1992)Carbohydr Res 233: 141–50.
Lehmann J, Petry S (1993)Liebigs Ann Chem 1111–16.
Toki D, Granovsky MA, Reck F, Kuhns W, Baker MA, Matta KL, Brockhausen I (1994)Biochem Biophys Res Commun 198: 417–23.
Alton G, Srivastava G, Kaur KJ, Hindsgaul O (1994)Bioorganic Medicinal Chem 2: 675–80.
Wilchek M, Givol D (1977)Methods Enzymol 46: 153.
Bayley H (1983) InPhotogenerated Reagents in Biochemistry and Molecular Biology, Laboratory Techniques in Biochemistry and Molecular Biology (Work, TS, Burdon RH, eds), Vol. 12, Amsterdam, The Netherlands:Elsevier.
Schramm VL, Horenstein BA, Kline PC (1994)J Biol Chem 269: 18259–62.
Pauling L (1946)Chem Eng News 24: 1375–77.
Palcic MM, Heerze LD, Srivastava OP, Hindsgaul O (1989)J Biol Chem 264: 17174–81.
Takaoka Y, Kajimoto T, Wong CH (1993)J Org Chem 58: 4809–12.
Schmidt RR, Frische K (1993)Bioorg Medicinal Chem Lett 3: 1747–50.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reck, F., Springer, M., Meinjohanns, E. et al. Synthetic substrate analogues for UDP-GlcNAc: Manα1-3R β1-2-N-acetylglucosaminyltransferase I. Substrate specificity and inhibitors for the enzyme. Glycoconjugate J 12, 747–754 (1995). https://doi.org/10.1007/BF00731234
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00731234